Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
123.64
-1.03 (-0.83%)
Oct 31, 2025, 10:17 AM EDT - Market open

Abbott Laboratories Revenue

Abbott Laboratories had revenue of $11.37B in the quarter ending September 30, 2025, with 6.90% growth. This brings the company's revenue in the last twelve months to $43.84B, up 6.37% year-over-year. In the year 2024, Abbott Laboratories had annual revenue of $41.95B with 4.59% growth.

Revenue (ttm)
$43.84B
Revenue Growth
+6.37%
P/S Ratio
4.95
Revenue / Employee
$384,588
Employees
114,000
Market Cap
214.99B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202441.95B1.84B4.59%
Dec 31, 202340.11B-3.54B-8.12%
Dec 31, 202243.65B578.00M1.34%
Dec 31, 202143.08B8.47B24.47%
Dec 31, 202034.61B2.70B8.48%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG56.37B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings